These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 14208792)
41. Fibrinolysis. V. The thrombolytic and anticoagulant activity of mold fibrinolysin (Aspergillin O) in vivo. MARIN HM; STEFANINI M; SOARDI F; MUELLER L J Lab Clin Med; 1961 Jul; 58():47-59. PubMed ID: 13766766 [No Abstract] [Full Text] [Related]
42. THE ANTITHROMBOSIS ACTIVITY OF THE HEPARINOID G 31150. JARRETT CL; JAQUES B Thromb Diath Haemorrh; 1964 Jan; 10():431-7. PubMed ID: 14113382 [No Abstract] [Full Text] [Related]
43. Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators. Collen D; Lu HR; Lijnen HR; Nelles L; Stassen JM Circulation; 1991 Sep; 84(3):1216-34. PubMed ID: 1909220 [TBL] [Abstract][Full Text] [Related]
44. [Actual state of thrombolytic treatment of recent vein thrombosis and pulmonary embolism (author's transl)]. Verstraete M J Mal Vasc; 1981; 6(4):251-6. PubMed ID: 7198677 [TBL] [Abstract][Full Text] [Related]
45. HEPARIN--A CAUSE OF ARTERIAL EMBOLI? ROBERTS B; ROSATO FE; ROSATO EF Surgery; 1964 Jun; 55():803-8. PubMed ID: 14168000 [No Abstract] [Full Text] [Related]
47. THROMBOEMBOLIC DISEASE ASSOCIATED WITH NORETHYNODREL. REPORT OF SIX CASES. SCHATZ IJ; SMITH RF; BRENEMAN GM; BOWER GC JAMA; 1964 May; 188():493-5. PubMed ID: 14159064 [No Abstract] [Full Text] [Related]
48. Prevention of venous thrombosis and pulmonary embolism in injured patients. ESKELAND G Lancet; 1962 May; 1(7238):1035-7. PubMed ID: 13890769 [No Abstract] [Full Text] [Related]
49. Venous thrombosis and pulmonary embolism. Their prevention by oral anticoagulants. SEVITT S Am J Med; 1962 Nov; 33():703-16. PubMed ID: 13988240 [No Abstract] [Full Text] [Related]
50. [The thrombolytic medications]. Rignault D Presse Med (1893); 1969 Jan; 77(2):55-8. PubMed ID: 4239477 [No Abstract] [Full Text] [Related]
51. [DETERMINATION OF ENDOTHELIUM-DAMAGING EFFECTS OF INJECTABLE SOLUTIONS. EFFECT OF THE OSMOTIC PRESSURE ON THE PH]. GOTTLOB R; ZINNER G Wien Klin Wochenschr; 1965 Mar; 77():149-57. PubMed ID: 14309377 [No Abstract] [Full Text] [Related]
52. PITFALLS IN THE THROMBOLYTIC TREATMENT OF VENOUS OCCLUSION. AMERY A; VERMYLEN J; MAES H; VERSTRAETE M Vasc Dis; 1964 Mar; 1():89-93. PubMed ID: 14186547 [No Abstract] [Full Text] [Related]
53. [OUR EXPERIENCES WITH LASTING ANTICOAGULANT THERAPY]. GORTVAI G; ADL M; KOVACS M Orv Hetil; 1964 Mar; 105():607-10. PubMed ID: 14138712 [No Abstract] [Full Text] [Related]
54. Role of fibrinolytic agents in thrombotic diseases. CHAPPLE RV; SINGHER HO J Am Med Assoc; 1960 May; 173():221-5. PubMed ID: 13809262 [No Abstract] [Full Text] [Related]
55. VENOUS THROMBOSIS AND PULMONARY EMBOLISM. KINLEY CE; DOLAN FG N S Med Bull; 1965 Feb; 44():44-6. PubMed ID: 14255803 [No Abstract] [Full Text] [Related]
57. FIBRINOLYTIC AGENTS IN TREATMENT OF TOTAL HYPHEMA AND SECONDARY GLAUCOMA. ROBERTS RA Tex State J Med; 1965 Mar; 61():181-3. PubMed ID: 14266135 [No Abstract] [Full Text] [Related]
58. Fibrinolysin (plasmin) therapy in acute deep thrombophlebitis. A controlled study. MOSER KM; SULAVIK SB; HAJJAR GC Circulation; 1960 Mar; 21():337-53. PubMed ID: 14424537 [No Abstract] [Full Text] [Related]
59. Thrombolytic therapy for deep vein thrombosis: potential application of plasmin. Marder VJ Thromb Res; 2009; 123 Suppl 4():S56-61. PubMed ID: 19303506 [TBL] [Abstract][Full Text] [Related]
60. Treatment of deep vein thrombosis with streptokinase. Duckert F; Müller G; Nyman D; Benz A; Prisender S; Madar G; Da Silva MA; Widmer LK; Schmitt HE Br Med J; 1975 Mar; 1(5956):479-81. PubMed ID: 123806 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]